An Afghan migrant who had returned from a visit to the Middle East 2 years before was seen with a non-healing painless lesion on the forearm ( Figure 1A ) . A skin biopsy showed intracellular Leishmania parasites in the subcutis ( Figure 1B and C ) , and the polymerase chain reaction (PCR) was positive for Leishmania tropica . At the same time, a German traveler who had returned from a vacation to Central America 1 month before was seen with progressively ulcerating painless lesions on the ankle, thigh, and forearm ( Figure 2A ) . Scarification of the lesions' margins showed sparse Leishmania amastigotes ( Figure 2B and C ) and the PCR from biopsies was positive for L . braziliensis . A 28-day treatment with oral miltefosine (2 mg and 2.5 mg/kg, respectively) was initiated in both individuals and the patients were seen at intervals of several weeks ( Figures 3 and 4 ) . All lesions healed, but both patients developed nausea and elevated liver function tests during pharmacotherapy. The highest values of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were 66 U/L and 44 U/L in the female migrant and 73 U/L and 33 U/L in the male traveler, respectively . Bilirubin levels were normal in both patients, but the male patient developed γGT levels of 113 U/L. All values returned to normal 2 and 3 weeks after the end of treatment, respectively. Neither patient's lesions showed clinical relapse when examined 4 months after the end of therapy. Miltefosine (hexadecylphosphocholine) has been shown to be effective in cutaneous and visceral leishmaniasis. 1 At least some strains of L. braziliensis , a species that can cause both cutaneous and mucocutaneous disease in the New World, have demonstrated a decreased sensitivity to the drug in vitro , however. 
